BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23803879)

  • 1. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
    Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
    Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between erythrocyte fatty acids in de novo lipogenesis pathway and DXA-derived body fat and trunk fat distribution in Chinese adults: a prospective study.
    Zeng FF; Chen ZY; Zheng JS; Lin JS; Li YH; Qiu R; Wang C; Sun LL; Chen YM
    Eur J Nutr; 2019 Dec; 58(8):3229-3239. PubMed ID: 30470880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.
    Jacobs S; Jäger S; Jansen E; Peter A; Stefan N; Boeing H; Schulze MB; Kröger J
    PLoS One; 2015; 10(5):e0127368. PubMed ID: 25984792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
    Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
    PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
    Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
    BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese.
    Zhang G; Sun Q; Hu FB; Ye X; Yu Z; Zong G; Li H; Zhou Y; Lin X
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E973-7. PubMed ID: 22456621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
    Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
    J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.
    Zong G; Ye X; Sun L; Li H; Yu Z; Hu FB; Sun Q; Lin X
    Am J Clin Nutr; 2012 Nov; 96(5):970-6. PubMed ID: 23015321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of erythrocyte fatty acid patterns with insulin resistance.
    Bigornia SJ; Lichtenstein AH; Harris WS; Tucker KL
    Am J Clin Nutr; 2016 Mar; 103(3):902-9. PubMed ID: 26864364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
    Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
    Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.
    Zeman M; Vecka M; Burda M; Tvrzická E; Staňková B; Macášek J; Žák A
    Metab Syndr Relat Disord; 2017 Sep; 15(7):371-378. PubMed ID: 28727953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
    Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
    Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.
    Chong MF; Hodson L; Bickerton AS; Roberts R; Neville M; Karpe F; Frayn KN; Fielding BA
    Am J Clin Nutr; 2008 Apr; 87(4):817-23. PubMed ID: 18400702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest.
    Lemaitre RN; King IB; Sotoodehnia N; Knopp RH; Mozaffarian D; McKnight B; Rea TD; Rice K; Friedlander Y; Lumley TS; Raghunathan TE; Copass MK; Siscovick DS
    Metabolism; 2010 Jul; 59(7):1029-34. PubMed ID: 20045147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
    Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
    Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.